Ana Petretić

Dr. Ana Petretić

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2024
Verified
Book Chapter
Open access
PDF file
Bozidar VujicicBozidar Vujicic
Bozidar Vujicic
KBKoraljka Benko
Koraljka Benko
APAna Petretić
Ana Petretić
NNNenad Nemarnik
Nenad Nemarnik
MSMatko Spicijarić
Matko Spicijarić
ARAlen Ruzic
Alen Ruzic
In patients with Congestive Heart Failure (CHF), neurohormonal activation leads to fluid overload that can be treated with high doses of furosemide unless diuretic resistance and hyponatremia develop. End-stage CHF, including patients with normal or slightly deteriorated kidney function, can resist medical treatment. In some cases of refractory CHF, ultrafiltration (UF) is required. To manage a refractory CHF population, extracorporeal UF is commonly used as an emergency treatment, but peritoneal UF should be considered a follow-up therapy option. This method offers potential advantages over extracorporeal therapies, including better preservation of residual renal function, tighter control of sodium balance, less neurohumoral activation, and the possibility of daily treatment in the home environment. Using glucose as an osmotic agent leads to the deterioration of the peritoneal membrane. The UF properties of icodextrin depend on the dwell time, whereby the maximum effect of icodextrin concerning glucose is achieved at a prolonged dwell time. Icodextrin may offer improved peritoneal membrane biocompatibility compared with conventional glucose-based dialysates by decreasing glucose exposure, iso-osmolarity, and reduced carbonyl stress. The proper anesthesia technique and surgical approach for peritoneal dialysis (PD) catheter placement in CHF patients must be based on the patient’s characteristics, available equipment, and surgeon’s experience. An open procedure using a transversus abdominis plane block for PD catheter placement in patients with CHF is strongly recommended.

1 April 2021 in Cardiologia Croatica
Verified
Journal Article
Closed access
APAna Petretić
Ana Petretić
LĆLea Skorup Ćutić
Lea Skorup Ćutić
ISIvana Smoljan
Ivana Smoljan
TCTamara Hlača Caput
Tamara Hlača Caput
SRSanja Matijević Rončević
Sanja Matijević Rončević
TJTeodora Zaninović Jurjević
Teodora Zaninović Jurjević

1 April 2023 in Cardiologia Croatica
Verified
Journal Article
Closed access
PBPetra Bulić
Petra Bulić
IRIvana Grgić Romić
Ivana Grgić Romić
ABAna-Marija Flego Bojić
Ana-Marija Flego Bojić
APAna Petretić
Ana Petretić
TJTeodora Zaninović Jurjević
Teodora Zaninović Jurjević

1 April 2023 in Cardiologia Croatica
Verified
Journal Article
Closed access
APAna Petretić
Ana Petretić
KBKoraljka Benko
Koraljka Benko
TCTamara Hlača Caput
Tamara Hlača Caput
ISIvana Smoljan
Ivana Smoljan
TNTin Nadarević
Tin Nadarević
TJTeodora Zaninović Jurjević
Teodora Zaninović Jurjević

1 April 2021 in Cardiologia Croatica
Verified
Journal Article
Closed access
TJTeodora Zaninović Jurjević
Teodora Zaninović Jurjević
EAErvin Avdović
Ervin Avdović
DPDanijel Premuš
Danijel Premuš
ABAna Lanca Bastiancic
Ana Lanca Bastiancic
APAna Petretić
Ana Petretić
LZLuka Zaputović
Luka Zaputović

10 June 2026 in Medicina
Verified
Journal Article
Open access
PDF file
FKFabio Kadum
Fabio Kadum
KBKoraljka Benko
Koraljka Benko
LBLara Baticic
Lara Baticic
APAna Petretić
Ana Petretić
Background and Objectives: Atrial fibrillation (AF) and atrial flutter are associated with significant morbidity. While electrical cardioversion (ECV) is a standard treatment for sinus rhythm restoration, early arrhythmia recurrence is common. Epicardial adipose tissue (EAT) is a metabolically active depot linked to atrial remodeling, yet its role in predicting post-ECV outcomes remains unclear. This study aimed to evaluate the association between EAT thickness measured by echocardiography and early arrhythmia recurrence following elective ECV in patients with and without heart failure (HF). Materials and Methods: A single-center observational study was conducted including 76 patients (38 with previously diagnosed HF) who underwent successful elective ECV (eECV) for AF or atrial flutter. Preprocedural transesophageal echocardiography was performed to exclude thrombi, while EAT thickness was assessed via transthoracic echocardiography (TTE). The primary outcome was early arrhythmia recurrence (within 30 days), and a secondary outcome was arrythmia recurrence in the HF subgroup. Data were analyzed using univariable and multivariable logistic regression, receiver operating characteristic (ROC) analysis, and subgroup analysis in patients with HF. Results: Arrhythmia recurrence occurred in 19 patients (25.0%) within the follow-up period. Mean EAT thickness did not differ significantly between patients with and without recurrence (3.74 ± 1.41 mm vs. 3.58 ± 1.78 mm; p = 0.42). EAT thickness did not emerge as a significant predictor of recurrence in univariable or multivariable models, demonstrating poor discriminative ability (AUC = 0.56). Similar findings were observed in the HF subgroup (OR = 0.94, p = 0.75; AUC = 0.49). Conversely, left atrial (LA) size was significantly associated with recurrence (OR = 2.76, p = 0.043). While EAT thickness correlated with body mass index and HF, it did not predict immediate rhythm outcomes. Conclusions: In our study, measurement of EAT thickness via TTE was not associated with early arrhythmia recurrence after eECV, including in patients with concomitant HF. These findings suggest that early post-cardioversion stability may depend more on established structural atrial remodeling, especially by LA enlargement, than on linear EAT thickness. Further research utilizing advanced volumetric imaging is warranted to clarify the role of epicardial adiposity in atrial arrhythmogenesis.